Planned sales, announced before they happen
1 trading plan running, 8 Form 144 notices for $51.6M
Plans running now
1
Jon M. Foster
What HCA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Jon M. Foster Executive Vice President and Chief Operating Officer |
Adopted 10b5-1 plan | Aug 11, 2026 | up to 10,000 | 547 days | 10-Q Oct 29, 2026 |
| Michael S. Cuffe Executive Vice President and Chief Clinical Officer |
Adopted 10b5-1 plan | May 6, 2025 | up to 10,920 | 369 days | 10-Q Aug 4, 2025 |
| Michael S. Cuffe Executive Vice President and Chief Clinical Officer |
Adopted 10b5-1 plan | May 7, 2024 | up to 22,080 | 365 days | 10-Q Jul 29, 2024 |
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 27, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Jon M Foster OFFICER |
31,742 | $16.3M | Exercise of a Stock Award; Vesting of a Stock Award | none given | 31,713 shares from Nov 4, 2026 |
| Nov 4, 2026 | Michael J Schlosser Officer |
1,200 | $594K | Exercise of a Stock Appreciation Right | none given | 1,200 shares from Nov 4, 2026 |
| Oct 29, 2026 | Michael S Cuffe Officer |
11,800 | $5.6M | Exercise of a Stock Apprectiation Right; Performance Award Vest | none given | none found |
| Feb 18, 2026 | Michael R McAlevey OFFICER |
1,694 | $903K | Exercise of a Stock Appreciation Right | none given | none found |
| Feb 11, 2026 | Jennifer L. Berres OFFICER |
8,020 | $4.1M | Vesting of a Stock Award | none given | none found |
| Feb 3, 2026 | MICHAEL S CUFFE OFFICER |
1,500 | $747K | Exercise of a Stock Appreciation Right | none given | none found |
| Feb 3, 2026 | Samuel N. Hazen President, Chief Executive Officer & Director |
42,877 | $21.5M | Exercise of a Stock Appreciation Right | none given | none found |
| Nov 5, 2025 | Michael R McAlevey OFFICER |
3,892 | $1.8M | Exercise of a Stock Appreciation Right | none given | none found |
From the Form 144 XML filed with the SEC, since Nov 5, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.